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Summary 
During antigen-induced immune responses, human B cells switch isotype from immunoglobulin 
M (IgM)-IgD to IgG1-4, IgA1-2, or IgE. In the human, no cytokines have yet been demonstrated 
to act as switch factors for IgG1,  IgG2, and IgG3.  In this paper, we report that in response 
to interleukin 10 (IL-10), anti-CD40 activated tonsillar surface IgD + (slgD +) B cells are induced 
to secrete large amounts of IgM, IgG1, and IgG3 but neither IgG2 nor IgG4. Cord blood purified 
B cells and lymphocytes from Hyper-IgM patients also produced IgG1 and IgG3 after culture 
with anti-CD40 and IL-10. In contrast, sIgD- isotype-committed B cells produce IgG1, IgG2, 
and IgG3 when activated through CD40 in the presence of IL-10. Thus, in addition to its growth- 
promoting and differentiating activities on human B calls, IL-10 may represent a switch factor 
for IgG1 and IgG3. 
H 
uman B lymphocytes can produce nine different iso- 
types of antibody induding IgM, IgD, IgG1-4, IgA1-2, 
and IgE. Each of the four subdasses of human IgG mole- 
cules, numbered according to their relative frequency in serum, 
exhibit a unique profile of effector functions allowing the 
elimination of pathogenic agents through different mecha- 
nisms (1). The IgG1 and IgG3 are predominantly produced 
in response to protein antigens (2) but chronic stimulation 
with such antigens results in an increased proportion of IgG4 
(1). In contrast, carbohydrate antigens most often induce IgG2 
responses (2). A certain commonalty in cytokine regulation 
of isotype switching between human and murine can be noted. 
In both species, IL-4 directs switching to IgE secretion (3, 
4) and mice with a disrupted IL-4 gene are unable to produce 
IgE (5). TGF-fl is involved in switching towards IgA in both 
species, although addition of IL-10 is necessary for human 
B cells (6, 7). IFN-'y is able to induce LPS-activated B cells 
to secrete IgG2a (8) and dextran-conjugated anti-IgD acti- 
vated B cells to produce both IgG2a and IgG3 (9). In vivo 
studies shows that administration of IFN-~/stimulates the 
IgG2a response. Likewise, mice treated with neutralizing anti- 
IFN-'y antibodies (10) and mice whose IFN-3' receptor gene 
has been inactivated (11), show a strong reduction of IgG2a 
responses. Evolution by duplication of a common ancestral 
3, chain gene in both species yidded four different IgG sub- 
classes, but this occurred early after spedation for the mouse 
and later in evolution for humans. Thus, different mecha- 
nisms are likely to be used for IgG subclass regulation in mice 
and in humans. However, it is interesting that IL-4 induces 
switching towards mouse IgG1 (12) and human IgG4 (13) 
which are both noncomplement-fixing  subclasses. Apart from 
IL-4 (13) and IL-13 (14) which are involved in the switch 
towards IgG4, the cytokines that direct the switch towards 
human IgG subclasses have not been identified. Activation 
through CD40 allows proliferation but not antibody secre- 
tion of naive surface (s)IgD +  slgM + B cells and further ad- 
dition of particles of Staphylococcus aureus (SAC) enhances their 
growth and induces them to secrete high levels of IgM. In 
the presence of IL-10,  naive slgD+slgM § B ceUs activated 
through CD40 are induced to secrete large amounts of IgM, 
IgG1, and IgG3, but neither IgG2 nor IgG4. This indicates 
that IL-10 may represent a switch factor for IgG1 and IgG3. 
Materials and Methods 
Reagentx  The anti-CD40  mAb89  was presented  by the CDw32/ 
FC3,RII transfected Ltk- cell line (CDw32 L cells) as described 
earlier (15). The mAbs used for phenotypic studies were FITC- 
conjugated anti-CD3, -CD19, -CD14, and -CD20 obtained from 
Becton Dickinson & Co. (Mountain View, CA). 
Each of the cytokines listed below was tested at various doses 
and below the optimal concentration point determined in specific 
bioassays as described  previously  (15). IL-lo~  and ID1/~ (10  s U/mg), 
IL-6 (107 U/mg), and TNF-o~ (2  x  107 U/mg) were purchased 
from C-enzyme  Corp. (Cambridge, MA). They were used at 10, 
100, 200, and 2.5 ng/ml, respectively.  Purified rhIL-2 (Amgen Bi- 
ologicals, Thousand Oaks, CA, 3  x  106 U/ml), rib3 (5  x  106 
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U/m1) (Schering-Plough  Research Institute) were used at 20 U/ml, 
10 ng/ml, 50 U/ml, and 100 ng/ml, respectively. Ib7 (provided 
by Dr. F. Lee, DNAX Research Institute, Palo Alto, CA) was used 
at 5% dilution (,~10 ng/ml) of a culture supematant of Cos7 ceils 
transfected with the human IL-7 eDNA clone. TGF-fll  (R&D 
Systems, Inc., Minneapolis, MN) was tested at 0.5 ng/ml. IFN-'y 
(107 U/mg) was purchased from Amgen Biologicals  and was used 
at 500 U/ml. 
Patient.  PBMC from a patient (T. G.) with X-linked Hyper- 
IgM syndrome reported previously (16) were used in this study. 
Isolation of slgD § and slgD- B Lymphocytes.  Mononuclear ceils 
from tonsils, peripheral blood, and cord blood were isolated by a 
standard Ficoll-Hypaque (dose =  1,077 g/ml) gradient method. 
Tonsillar B cells were first enriched in the E-  fraction and sub- 
mitted to anti-CD2,  -CD3, and -CD14 mAb negative selection 
with magnetic beads coated with anti-mouse IgG (Dynabeads; 
Dynal, Oslo, Norway). Purified  B lymphocytes  were separated  using 
a preparative magnetic cell sorter (MACS  |  Becton Dickinson & 
Co.). The separation based on sIgD expression has been described 
in details earlier (7). IgD was expressed on >99%  of the sIgD + 
B cell subpopuhtion and <1% of slgD- B cell subpopulation, as 
assessed by fluorescence  analysis  using a FACScan  |  (Becton Dick- 
inson & Co.). 
Culture in the CD40 System.  For Ig production,  2.5  x  104 
purified B cells or PBMC were cultured in the presence of 2.5  x 
103 irradiated (7,000 rad) CDw32 L cells and 0.5/xg/ml of anti- 
CD40 mAb89 in a final vohme of 200 #1 (15). Formalinized parti- 
cles orS. aureus strain Cowan I (SAC) were purchased as Pansorbin 
from Calbiochem-Novabiochem  Corp. (La  Jolla, CA) and were used 
at the final concentration of 0.005% (vol/vol). Supernatants were 
harvested after 10 d (unless otherwise stated) and IgG, IgA, and 
IgM levels were determined by ELISA. 
ELISAsfor IgG Subclasses.  ELISA  specific for IgG subclasses 
was used as described in detail dsewhere (17). Flat-bottomed mi- 
crotiter plates (Nunc, Roskilde, Denmark) were directly coated for 
the  titration  of human  IgG4 with  mouse  anti-human  IgG4 
(HP6023, used at  1 ttg/ml) (Calbiochem) or coated with rat 
anti-mouse  IgG1, mAb  LO-MGl-13,  provided by Dr.  Bazin 
(University of Louvain, Brussds, Bdgium) used at 5 ttg/ml in car- 
bonate buffer (pH 9.6) for the titrations of IgG1, IgG2, and IgG3. 
After incubation for  18  h  at  4~  the  plates were washed in 
PBS/0.05% Tween (Merck Sharp & Dohme, West Point, PA) and 
were incubated 2 h at room temperature with mouse anti-human 
IgG1 (M15015 used at 0.5 ttg/ml) (Oxoid Unipath Ltd., Hamp- 
shire, UK) or mouse  anti-human IgG2 (HP6002 used at 0.75/zg/ml) 
(Calbiochem) or mouse anti-human IgG3 (HP6050 used at 0.75 
/~g/ml) (Calbiochem) in PBS/Tween-1% BSA. Next, the culture 
supematants were diluted  to  the appropriate concentration in 
PBS/4% nonfat milk, added to the plates, and incubated for 2 h 
at room temperature. A standard human serum (Janssen, Am- 
sterdam, The Netherlands) was used as reference. The plates were 
then washed and a goat anti-human IgG Fc coupled to alkaline 
phosphatase (A-9544) (Sigma Chemical Co., St. Louis, MO) was 
added at a final dilution of 1:2,000 in PBS/Tween-1% BSA for 2 
h at room temperature. After washing, IgG subclasses were mea- 
sured by incubation with p-nitrophenyl phosphate (Sigma) in 1 M 
diethanolamine/HC1  buffer, pH 9.8, and the plates were read with 
a V-MAX F_LISA  reader (Molecular  Devices, Palo Alto, CA). The 
limits of sensitivity were 50, 90, 65, and 30 ng/ml for IgG1, IgG2, 
IgG3 and IgG4, respectively. 
Results  and  Discussion 
Total tonsiUar B cells cultured in the CD40 system, com- 
posed ofa fibroblast cell line expressing a CDw32/Fc~ receptor 
and a mAb specific for the CD40 antigen, proliferate strongly 
while producing only small amounts oflgs (15, 18, 19). Un- 
separated tonsillar B cells cultured in the CD40 system alone 
produced very little IgM and none of the four IgG subclasses 
(Table 1). Addition of 100 ng/ml IL-10 to these cultures in- 
duced B cells to produce considerable amounts oflgM (20,500 
ng/ml) and IgG (',,80,000 ng/ml) after 10 d of culture (7, 
19) (Table 1). Furthermore, in response to IL-10, anti-CD40 
activated B cells produced high levels of IgG1, IgG2, and 
IgG3, representing 80-85%, 4-17%, and 2-5% of the secreted 
IgG, respectively. 
Tonsillar B cells consist of naive B cells, expressing surface 
IgM and IgD, and isotype-committed B cells that have un- 
dergone isotype switch and express surface IgG, IgA, or IgE 
but have lost expression oflgD and IgM. Naive B cells, sepa- 
rated according to slgD expression,  did not produce detect- 
able amounts of IgM and IgG when triggered through the 
CD40 antigen (7) (Fig.  1). Addition of IL-10 enhanced IgM 
production from a mean value of 120-19,200  ng/ml (mean 
of eight separate experiments, Fig. 1 A), in agreement with 
the notion that I1-10 is a potent B cell differentiation factor 
(19). Most importantly, in response  to IL-10, naive B lym- 
phocytes were induced to secrete IgG from levels <50 ng/ml 
to a mean value of 3,700 ng/ml (mean of eight separate ex- 
periments, Fig.  1 B). As shown in Fig. 1 C, IL-10 was the 
only one among 12 recombinant cytokines with recognized 
B cell tropism (19) to enhance the production oflgG by anti- 
CD40 activated naive B cells. 
Table  1.  Unseparated  B  Cells Cultured in the CD40 System Secrete IgGI,  IgG2,  and IgG3 in Response to IL-IO 
IL-10  IgG1  IgG2  IgG3  IgG4  IgM 
ng/ml 
-  <50  <90  <65  <30  50  _+  5 
+  68,520  _+  1,050  14,235  +  500  1,830  +  280  <30  20,500  +  2,300 
Purified tonsillar B cells (5  x  104 cells/well; >99% CD20+) were cultured in flat*bottom  microwells for 10 d on 5 x 103 irradiated CDw32 L 
cells with 0.5/zg/ml mAb89 without or with 100 ng/ml IL-10. Supernatants  were harvested after 10 d and Ig levels were determined  by ELISA. 
Results are means _+ SD of quadruplicates culture. Representative of one out of three experiments. 
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Figure  1.  11,10 induces anti-CD40 activated naive slgD + slgM + B 
cells to secrete high levels of IgM and IgG. (.4 and B) 5  x  104 MACS  | 
purified slgD + B cells were cultured for 10 d with 5  x  103 irradiated 
CDw32 L cells  with mAb89 without or with 100 ng/ml Ibl0. The results 
of eight experiments performed over a 2-yr period are shown. (C) B cells 
were cultured with medium alone, 10 ng/ml Iblo~, 100 ng/ml I1.1/5, 20 
U/ml I1.2, 10 ng/ml I1.3, 50 U/ml I1.4, 10 ng/ml I1.5, 200 ng/ml I1.6, 
10 ng/ml I1.7, 100 ng/ml 11.10, 0.5 ng/mt TGF-fll, 500 U/ml IFN-',/, 
and 2.5 ng/ml TNF-c~. Supernatants were harvested after 10 d and IgM 
and lgG levels were determined by ELISA. Results are means of quadru- 
plicate cultures. 
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Figure 2.  IL-10  induces naive slgD + B cells to produce lgG1 and lgG3 
and isotype-committed slgD- B cells to secrete IgG1, IgG2, and IgG3. 
5 x  104 MACS|  slgD + and slgD- B cells were cultured for 7, 
14, and 21 d with 5  x  103 irradiated CDw32 L cells with mAb89 in 
the presence of 100 ng/ml II--10. Supernatams were harvested and IgG 
subclasses levels  were determined by ELISA. [g levels  were also measured 
in day 28 supernatants (data not shown) and found comparable to those 
of  day 21 supematants. Results are means + SD of  quadruplicate cultures. 
Representative of three experiments. 
A more detailed analysis of IgG production demonstrated 
a differential effect of IL-10 on the various IgG subclasses. 
IL-10 induced naive slgD § B cells to synthesize exclusively 
IgG1  and IgG3 (Fig.  2).  After 3  wk of culture,  IgG1 and 
IgG3  production  by  slgD +  B  cells  reached  a  maximum 
(5,750  and 4,400  ng/ml,  respectively)  whereas  these cells 
secreted <90  ng/ml IgG2 and <50 ng/ml  IgG4.  The lack 
of IgG2 production was not due to inhibition by IL-10 since 
IL-10 induced high levels of IgG2 from the isotype-committed 
slgD-  B  cell population  (Fig.  2).  The difference between 
IgG2 levels induced in naive and isotype-committed popula- 
tions also indicates that contamination of the naive B cell 
population by isotype-committed B cells was minimal. Thus, 
the high levels of IgG1 and IgG3 produced by the naive B 
cells in response to IL-10 strongly suggest that they result 
from isotype switch. The kinetics of IgG1 and IgG3 produc- 
tion  were  also  consistent  with  switching,  since  isotype- 
committed B cells secreted 5,300 ng/ml IgG1 and 540 ng/ml 
IgG3 as early as 7 d after stimulation whereas these isotypes 
remained undetectable in the supernatants  of naive B cells. 
The delay in IgG subclasses secretion is consistent with the 
time required for the genetic recombination  within the H 
chain locus to occur. This IgG1- and IgG3-inducing activity 
of IL-10 was not related to the organ origin of the B  cells 
as identical results had been obtained with B cells isolated 
from spleens  (data not  shown). 
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tion of IgM as well as IgG1 and IgG3, the results presented 
above do not allow discrimination between the respective roles 
of IL-10 and anti-CD40 in inducing the actual isotype switch. 
To distinguish  between these two potential switch  signals, 
we used S.  aureus  Cowan  I  strain  (SAC)  as  a costimulus  in 
the anti-CD40  system. Addition  of SAC resulted in the in- 
duction of considerable IgM secretion (30,000 ng/ml) by naive 
tonsillar B cells, but IgG levels were still undetectable  (Fig. 
3 A). When IL-10 was added to the anti-CD40/SAC system, 
IgM secretion was moderately enhanced (fourfold), whereas 
IgG1 and  IgG3 were  strongly induced  (from undetectable 
values to 2,910 and 3,030 ng/ml, respectively), and IgG2 or 
IgG4 were still undetectable.  By comparison, unseparated B 
cells activated through CD40 and SAC secreted considerable 
amounts of IgM but  also IgG1, IgG2,  and  IgG3, without 
adding exogeneous cytokines. Addition of IL-10 to the anti- 
CD40/SAC system further enhanced the production of IgM 
(25-fold),  IgG1 (threefold),  IgG2 (2.6-fold),  and Igg3 (40- 
fold) from unseparated B cells (Fig. 3 B). These results indi- 
cate that  IL-10 rather  than  anti-CD40  was responsible for 
the secretion of IgG1 and IgG3 and that the effect on IgG3 
was particularly striking on naive B  cells as well as on un- 
separated B lymphocytes. Furthermore, limiting dilution anal- 
ysis indicated  that  IL-10 acted  through  increasing  the fre- 
quency of slgD + B  cells secreting either  IgG1 (1:1,800)  or 
IgG3 (1:600) in the anti-CD40/SAC  system, whereas in the 
absence of IL-10, <1:5,000  B  cells produced  IgG1 or IgG3 
(data  not  shown). 
Cells isolated from cord blood were used as another source 
ofB lymphocytes, since this population does not contain de- 
tectable numbers of isotype-committed cells. However, neo- 
natal B cells, which  are deficient in their ability to produce 
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Figure  3.  IL-10  further enhances IgM secretion by naive slgD § B cells 
in the CD40/SAC system and induces secretion of IgG1 and IgG3.5  ￿ 
104 MACS|  slgD + B cells (A) or unseparated B cells (B) were 
cultured for 14 d with 5  ￿  103 irradiated CDw32 L cells with mAb89 
and SAC (0.05% vol/vol) in the presence of 100 ng/ml IL-10. Superna- 
tants were harvested and IgG subclasses  levels  were determined by ELISA. 
Results are means _+ SD of quadruplicate cultures. Representative of five 
experiments. 
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Figure  4.  Ibl0 induces IgG1 and IgG3 by naive B cells from cord blood 
or from PBMC from Hyper-IgM patients. 5  x  104 B cells purified from 
cord blood (>98%  CD19  + and >98% slgD +) and total blood mono- 
nuclear cells (PBMNC) (due to cell number limitation) of a Hyper-IgM 
patient (G. T.) were cultured with 5 x  103 irradiated L cells with mAb89 
without or with 100 ng/ml IL-IO. Supernatants were harvested after 14 d 
and IgG subclass levels were determined by ELISA. Results are means 
+ SD of quadruplicate cultures. Two experiments for (A) and one for (B). 
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shown in Fig. 4 A, neonatal B lymphocytes isolated from 
cord blood behaved similarly to naive cells purified from tonsils. 
None of the IgG subclasses were produced when cord blood 
B ceils were cultured in anti-CD40/SAC system alone. Addi- 
tion of IL-10 resulted in  the production of considerable 
amounts of both IgG1 and IgG3 but not IgG2 and IgG4. 
The Hyper-IgM syndrome was recently demonstrated to be 
due to a defective CD40 ligand on T  cells, accounting for 
their inability to drive an isotype switch (16, 21, 22). B cells 
from these patients can be induced to switch isotype in vitro 
when cocultured with a malignant human T  cell line (23) 
or after CD40 triggering in the presence of cytokine (16, 
21). As shown in Fig.  4 B, PBMC from one such patient 
cultured in the anti-CD40/SAC system behaved similarly to 
naive B calls from normal individuals. They did not secrete 
IgG when stimulated with anti-CD40/SAC system alone, 
but secreted IgG1 and IgG3 but neither IgG2 nor IgG4 after 
addition of IL-10. 
Taken together, the present data support the notion that 
IL-10 induces naive sIgD + B cells to switch towards IgG1 
and IgG3 because (a) naive B cells exclusively synthesize IgG1 
and IgG3 in response to IL-10 and do not produce IgG2; 
(b) different sources of naive B ceils yield the same isotypes; 
and (c) naive B calls produced these isotypes with a delayed 
kinetics when compared to isotype-committed B cells. 
The CD40 system shares many of the important features 
occurring within the germinal centers of the lymphoid fol- 
licles. Indeed, CD40 activation was sufficient to restore the 
switching capacity of Hyper-IgM B  ceils in response to 
cytokines. Thus, the triggering of CD40 plays a key role in 
isotype switching, possibly by turning on the isotype switch 
machinery, which supposedly alters the DNA structure of 
the H chain locus. Cytokines, on the other hand, are consid- 
ered to provide isotype specificity. Indeed, IL-10 alone in- 
duces switching towards IgG1 and IgG3, and together with 
TGF-~ towards IgA (7), whereas IL-4 and IL-D induce IgE 
and IgG4. Yet to be resolved is the cytokine(s) that induces 
the switch towards IgG2, an isotype most often found in 
response to carbohydrate antigens (2). 
This study brings up a novel activity of IL-10, namely its 
ability to induce human naive B cells to switch isotype from 
IgM to IgG1 and IgG3. This function is additional to IL- 
10's B cell differentiation activity (7, 19) that induces isotype- 
committed slgD- B cells to secrete IgG1, IgG2, and IgG3. 
Isotype switching was induced in different sources of human 
naive B cells including highly purified tonsillar or splenic 
sIgD + B, neonatal B, and B cells from the Hyper-IgM pa- 
tient. Further studies at the molecular level are required to 
determine the respective contribution of IL-10, CD40 trig- 
gering, and SAC. It is possible that IL-10 may not account 
for all IgG3 and particularly IgG1 switch-inducing activity. 
The ratio IgG1/IgG3 is dose to 1 in culture supernatants 
of naive adult B and in neonatal B cells, whereas it is dose 
to 10 in culture supernatants of unseparated B ceils and in 
serum. The in vivo prevalence of IgG1 could be due to the 
existence of another factor inducing or enhancing switching 
to IgG1.  In this context, several Ig isotypes are under the 
control of redundant molecules, such as switching to human 
IgG4 and IgE in response to IL-4 or IL-13. It is interesting 
to note that the IgG1 and IgG3 isotypes whose switch is 
directed by IL-10, preferentially bind to those Fc,/receptors 
(rmTRI, II, and III) whose expression are modulated on mono- 
cytes by IL-10 (24). Finally, this study raises the possibility 
that patients suffering from IgG3 and IgG1 deficiencies may 
either display reduced IL-10 secretion, produce IL-10 antag- 
onists, or show an intrinsic B cell impairment resulting in 
defective IL-10 responses. 
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